Format
Sort by

Send to:

Choose Destination

Search results

Items: 4

1.

Preclinical evaluation of [18F]2FNQ1P as the first fluorinated serotonin 5-HT6 radioligand for PET imaging.

Becker G, Colomb J, Sgambato-Faure V, Tremblay L, Billard T, Zimmer L.

Eur J Nucl Med Mol Imaging. 2015 Mar;42(3):495-502. doi: 10.1007/s00259-014-2936-y. Epub 2014 Oct 21.

PMID:
25331460
2.

Radiosynthesis and characterization of 11C-GSK215083 as a PET radioligand for the 5-HT6 receptor.

Parker CA, Gunn RN, Rabiner EA, Slifstein M, Comley R, Salinas C, Johnson CN, Jakobsen S, Houle S, Laruelle M, Cunningham VJ, Martarello L.

J Nucl Med. 2012 Feb;53(2):295-303. doi: 10.2967/jnumed.111.093419. Epub 2012 Jan 5.

3.

Biodistribution and radiation dosimetry of the serotonin 5-HT₆ ligand [¹¹C]GSK215083 determined from human whole-body PET.

Comley RA, Salinas C, Mizrahi R, Vitcu I, Ng A, Hallett W, Keat N, Wilson AA, Rabiner EA, Laruelle M, Houle S.

Mol Imaging Biol. 2012 Aug;14(4):517-21. doi: 10.1007/s11307-011-0523-1.

PMID:
22076076
4.

In vivo 5-HT(6) receptor occupancy by antipsychotic drugs in the rat brain.

Hirano K, Searle KL, Nasir S, Aw CC, Browne ER, Rutter AR.

Neurosci Lett. 2011 Oct 10;503(3):240-3. doi: 10.1016/j.neulet.2011.08.044. Epub 2011 Aug 27.

PMID:
21896308
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk